Amit Mahipal

48PUBLICATIONS
167CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Jul 28, 2026
Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Advanced Hepatocellular Carcinoma: A Propensity-Score-Matched Analysis.

|Jul 10, 2026
Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers.

|Jan 28, 2026
Glucagon-like Peptide-1 Receptor Agonist Use and Pancreatic Cancer Risk in Patients with Chronic Pancreatitis.

Sarina Ailawadi, Jennifer E Murphy, Michael H Storandt

|Jul 02, 2025
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma.

Maen Abdelrahim, Alejandro Mejia, Abdullah Esmail

|Apr 16, 2025
Safety and Efficacy of Anti-Human Epidermal Growth Factor 2 Agents in the Treatment of Biliary Tract Cancers: A Systematic Review.

Nikolas Naleid, Omkar Pawar, Sakti Chakrabarti

|Mar 31, 2025
Frequency and outcomes of BRAF alterations identified by liquid biopsy in metastatic, non-colorectal gastrointestinal cancers.

Amit Mahipal, Leslie Bucheit, Nicole Zhang

Pageof 8

Frequent Collaborators

14 joint publications

Zhaohui Jin

14 joint publications

Sakti Chakrabarti

6 joint publications

Michael H Storandt

5 joint publications

Mitesh J Borad